The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

30 articles for D Guo


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as SelectiveaEBI
Chinese Academy of Sciences
5'-Substituted Amiloride Derivatives as Allosteric Modulators Binding in the Sodium Ion Pocket of the Adenosine A2A Receptor.EBI
Leiden University
Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists.EBI
Leiden University
Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.EBI
Leiden University
Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.EBI
Adolor
Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.EBI
National Institute of Diabetes
P3 cap modified Phe*-Ala series BACE inhibitors.EBI
Eli Lilly
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.EBI
Eli Lilly
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers.EBI
HUTCHMED Limited
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease.EBI
Xuzhou Medical University
Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.EBI
Xuzhou Medical University
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.EBI
Xuzhou Medical University
A Novel Bifunctional μOR Agonist and σEBI
Sichuan University
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.EBI
Xuzhou Medical University
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin VEBI
Xuzhou Medical University
Discovery of Novel EBI
Shenyang Pharmaceutical University
Long Residence Time at the Vasopressin VEBI
Xuzhou Medical University
Benzodiazepine Derivatives as Potent Vasopressin VEBI
Xuzhou Medical University
Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.EBI
Wuhan University
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.EBI
Hangzhou Institute For Advanced Study
Amino acid conjugates as kappa opioid receptor agonists.EBI
Adolor
Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.EBI
Adolor
Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC.EBI
Chongqing Medical University
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.EBI
Eli Lilly
3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.EBI
Currently Naeja Pharmaceutical
Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.EBI
Currently Naeja Pharmaceutical
Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.EBI
Heptares Therapeutics
Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.EBI
University of Maryland
Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.EBI
Central South University
Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.EBI
Central South University